Exploring Novel Aptamer-Heparin Combinations to Improve Anticoagulation Therapy in Cardiopulmonary Bypass

被引：0
|
作者：
Chabata, Charlene V. [1 ]
Gunaratne, Ruwan [1 ]
Frederiksen, James W. [1 ]
Sullenger, Bruce A. [1 ]
机构：
[1] Duke Univ, Pharmacol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
784
引用
收藏
页码：364 / 365
页数：2
相关论文
共 50 条
  • [1] Anticoagulation for cardiopulmonary bypass: Is a replacement for heparin on the horizon?
    Warkentin, TE
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 131 (03): : 515 - 516
  • [2] Alternatives to unfractioned heparin for anticoagulation in cardiopulmonary bypass
    von Segesser, LK
    Mueller, X
    Marty, B
    Horisberger, J
    Corno, A
    PERFUSION-UK, 2001, 16 (05): : 411 - 416
  • [3] Anticoagulation for cardiopulmonary bypass of a patient with ''heparin allergy''
    Ochroch, E
    Shorten, GD
    Rvaula, RE
    Comunale, ME
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1997, 11 (05) : 622 - 624
  • [4] Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass
    Ruwan Gunaratne
    Shekhar Kumar
    James W Frederiksen
    Steven Stayrook
    Jens L Lohrmann
    Kay Perry
    Kristin M Bompiani
    Charlene V Chabata
    Nabil K Thalji
    Michelle D Ho
    Gowthami Arepally
    Rodney M Camire
    Sriram Krishnaswamy
    Bruce A Sullenger
    Nature Biotechnology, 2018, 36 : 606 - 613
  • [5] Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass
    Gunaratne, Ruwan
    Kumar, Shekhar
    Frederiksen, James W.
    Stayrook, Steven
    Lohrmann, Jens L.
    Perry, Kay
    Bompiani, Kristin M.
    Chabata, Charlene V.
    Thalji, Nabil K.
    Ho, Michelle D.
    Arepally, Gowthami
    Camire, Rodney M.
    Krishnaswamy, Sriram
    Sullenger, Bruce A.
    NATURE BIOTECHNOLOGY, 2018, 36 (07) : 606 - +
  • [6] Anticoagulation for patients with antiphospholipid antibodies undergoing cardiopulmonary bypass - a novel strategy for optimisation of heparin anticoagulation
    Ryan, K.
    Goodyer, M.
    O'Connell, N.
    Gilmore, R.
    Ni Ainle, F.
    Jenkins, V
    Fagan, P.
    Young, V
    O'Donnell, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 991 - 991
  • [7] ANCROD (ARVIN) AS AN ALTERNATIVE TO HEPARIN ANTICOAGULATION FOR CARDIOPULMONARY BYPASS
    ZULYS, VJ
    TEASDALE, SJ
    MICHEL, ER
    SKALA, RA
    KEATING, SE
    VIGER, JR
    GLYNN, MFX
    ANESTHESIOLOGY, 1989, 71 (06) : 870 - 877
  • [8] THE INFLUENCE OF PREOPERATIVE ANTICOAGULATION ON HEPARIN RESPONSE DURING CARDIOPULMONARY BYPASS
    DIETRICH, W
    SPANNAGL, M
    SCHRAMM, W
    VOGT, W
    BARANKAY, A
    RICHTER, JA
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (04): : 505 - 514
  • [9] Alternatives to heparin and protamine anticoagulation for cardiopulmonary bypass in cardiac surgery
    Bouraghda, Aurore
    Gillois, Pierre
    Albaladejo, Pierre
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2015, 62 (05): : 518 - 528
  • [10] Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia
    Dragomer, D.
    Chalfant, A.
    Biniwale, R.
    Reemtsen, B.
    Federman, M.
    PERFUSION-UK, 2011, 26 (06): : 516 - 518
12345